Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Stake Cut by Arkadios Wealth Advisors

Arkadios Wealth Advisors lessened its holdings in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 23.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,460 shares of the real estate investment trust’s stock after selling 4,688 shares during the quarter. Arkadios Wealth Advisors’ holdings in Sabra Health Care REIT were worth $268,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. ORG Partners LLC boosted its holdings in shares of Sabra Health Care REIT by 2,031.8% during the fourth quarter. ORG Partners LLC now owns 25,283 shares of the real estate investment trust’s stock worth $438,000 after purchasing an additional 24,097 shares during the period. JPMorgan Chase & Co. lifted its position in Sabra Health Care REIT by 222.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust’s stock worth $183,996,000 after buying an additional 6,819,919 shares in the last quarter. Franklin Resources Inc. lifted its position in Sabra Health Care REIT by 12.3% in the 3rd quarter. Franklin Resources Inc. now owns 524,917 shares of the real estate investment trust’s stock worth $9,543,000 after buying an additional 57,551 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in shares of Sabra Health Care REIT during the 3rd quarter valued at $59,000. Finally, Geode Capital Management LLC grew its holdings in shares of Sabra Health Care REIT by 1.7% during the 3rd quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust’s stock valued at $117,165,000 after acquiring an additional 104,533 shares in the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on SBRA. Mizuho reiterated a “neutral” rating and set a $20.00 price objective on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Truist Financial lowered Sabra Health Care REIT from a “buy” rating to a “hold” rating and reduced their price target for the company from $18.00 to $17.00 in a report on Friday, January 17th. Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 7th. JMP Securities upgraded shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 target price for the company in a research note on Tuesday, January 7th. Finally, Scotiabank increased their price target on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a “sector perform” rating in a research note on Friday, October 11th. Three analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $19.13.

Sabra Health Care REIT Stock Up 0.9 %

Shares of Sabra Health Care REIT stock opened at $16.75 on Friday. Sabra Health Care REIT, Inc. has a 12-month low of $12.83 and a 12-month high of $20.03. The company has a quick ratio of 4.16, a current ratio of 4.16 and a debt-to-equity ratio of 0.90. The stock has a 50 day moving average price of $17.54 and a two-hundred day moving average price of $17.55. The stock has a market capitalization of $3.96 billion, a P/E ratio of 40.85, a PEG ratio of 2.05 and a beta of 1.26.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by ($0.22). The firm had revenue of $178.00 million for the quarter, compared to the consensus estimate of $177.19 million. Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. During the same period in the prior year, the company posted $0.34 earnings per share. Equities analysts expect that Sabra Health Care REIT, Inc. will post 1.39 earnings per share for the current year.

Sabra Health Care REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 29th. Investors of record on Friday, November 15th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 7.16%. Sabra Health Care REIT’s dividend payout ratio is presently 292.69%.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.